Cargando…
Hadrontherapy for Thymic Epithelial Tumors: Implementation in Clinical Practice
Radiation therapy is part of recommendations in the adjuvant settings for advanced stage or as exclusive treatment in unresectable thymic epithelial tumors (TETs). However, first-generation techniques delivered substantial radiation doses to critical organs at risk (OARs), such as the heart or the l...
Autores principales: | Loap, Pierre, Vitolo, Viviana, Barcellini, Amelia, De Marzi, Ludovic, Mirandola, Alfredo, Fiore, Maria Rosaria, Vischioni, Barbara, Jereczek-Fossa, Barbara Alicja, Girard, Nicolas, Kirova, Youlia, Orlandi, Ester |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543015/ https://www.ncbi.nlm.nih.gov/pubmed/34707989 http://dx.doi.org/10.3389/fonc.2021.738320 |
Ejemplares similares
-
Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to Evidence
por: Loap, Pierre, et al.
Publicado: (2021) -
Development and Implementation of Proton Therapy for Hodgkin Lymphoma: Challenges and Perspectives
por: Loap, Pierre, et al.
Publicado: (2021) -
Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review
por: Loap, Pierre, et al.
Publicado: (2021) -
PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?
por: Barcellini, Amelia, et al.
Publicado: (2021) -
The Role of Carbon Ion Therapy in the Changing Oncology Landscape—A Narrative Review of the Literature and the Decade of Carbon Ion Experience at the Italian National Center for Oncological Hadrontherapy
por: Orlandi, Ester, et al.
Publicado: (2023)